Literature DB >> 31352566

Hope, hype and biology: the current biomarker landscape in bladder cancer.

Peter C Black1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31352566     DOI： 10.1007/s00345-019-02885-6

Source DB:  PubMed          Journal:  World J Urol        ISSN： 0724-4983            Impact factor:   4.226


× No keyword cloud information.
  6 in total

Review 1.  Forty years of cisplatin-based chemotherapy in muscle-invasive bladder cancer: are we understanding how, who and when?

Authors:  Julian Schardt; Beat Roth; Roland Seiler
Journal:  World J Urol       Date:  2018-11-03       Impact factor: 4.226

Review 2.  The role of biomarkers in bladder preservation management of muscle-invasive bladder cancer.

Authors:  Timur Mitin; Ananya Choudhury
Journal:  World J Urol       Date:  2018-09-14       Impact factor: 4.226

3.  The molecular limitations of biomarker research in bladder cancer.

Authors:  Panagiotis J Vlachostergios; Bishoy M Faltas
Journal:  World J Urol       Date:  2018-08-31       Impact factor: 4.226

Review 4.  Can urinary biomarkers replace cystoscopy?

Authors:  Moritz Maas; Jens Bedke; Arnulf Stenzl; Tilman Todenhöfer
Journal:  World J Urol       Date:  2018-10-03       Impact factor: 4.226

Review 5.  Molecular predictors of response to PD-1/PD-L1 inhibition in urothelial cancer.

Authors:  Viktoria Stühler; Jan Moritz Maas; Jonas Bochem; Inês Anselmo da Costa; Tilman Todenhöfer; Arnulf Stenzl; Jens Bedke
Journal:  World J Urol       Date:  2018-10-29       Impact factor: 4.226

Review 6.  The current role and future directions of circulating tumor cells and circulating tumor DNA in urothelial carcinoma of the bladder.

Authors:  Michael Rink; Heidi Schwarzenbach; Sabine Riethdorf; Armin Soave
Journal:  World J Urol       Date:  2018-10-26       Impact factor: 4.226
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.